Gao Yali, Luo Xiaoling, Meng Ting, Zhu Minjuan, Tian Meiwen, Lu Xiaohe
Department of Ophthalmology, Second Clinical Medical College of Ji'nan University/Shenzhen People's Hospital, Shenzhen 518020, China.
Department of Ophthalmology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Sep 30;40(9):1239-1245. doi: 10.12122/j.issn.1673-4254.2020.09.03.
To investigate whether DNMT1 protein induces retinoblastoma proliferation by silencing MEG3 gene.
Two retinoblastoma cell lines (HXO-RB44 and SO-RB50) and a normal human retinal pigment epithelial (RPE) cell line were transfected with the plasmid pcDNA-DNMT1 or si-DNMT1 for up-regulating or interference of DNMT1 expression, and with pcDNA-MEG3 or si-MEG3 for up-regulating or interference of MEG3 expression. Western blotting was used to detect the changes in the expression of DNMT1 protein in the transfected cells, and CCK-8 and EdU assays were used to detect the changes in cell proliferation. Real-time quantitative PCR (qRT-PCR) was performed to detect MEG3 expression in SO-RB50 and HXO-RB44 cells after transfection, and the methylation level of MEG3 gene promoter after interference of DNMT1 expression was detected using methylation-specific PCR.
SO-RB50 and HXO-RB44 cells showed significantly increased expression of DNMT1 protein as compared with normal RPE cells ( < 0.05). In HXO-RB44 cells, transfection with pcDNADNMT1 resulted in significantly increased expression of DNMT1 protein, enhanced cell proliferation ability, and significantly reduced expression of MEG3 ( < 0.05). In SO-RB50 cells, transfection with si-DNMT1 significantly reduced the expression of DNMT1 protein, suppressed the cell proliferation, and increased MEG3 expression ( < 0.05). Interference of DNMT1 significantly reduced the methylation level of MEG3 gene promoter. After reversing the regulatory effect of DNMT1 on MEG3 gene, DNMT1 protein showed significantly weakened ability to regulate retinoblastoma cell proliferation ( < 0.05).
In retinoblastoma cells, the up-regulation of DNMT1 protein induces promoter methylation and inactivation of MEG3 gene and eventually leads to abnormal cell proliferation.
探讨DNA甲基转移酶1(DNMT1)蛋白是否通过沉默母系表达基因3(MEG3)来诱导视网膜母细胞瘤增殖。
将质粒pcDNA-DNMT1或小干扰RNA(si-DNMT1)转染至两种视网膜母细胞瘤细胞系(HXO-RB44和SO-RB50)及人正常视网膜色素上皮(RPE)细胞系,上调或干扰DNMT1表达;将质粒pcDNA-MEG3或si-MEG3转染上述细胞系,上调或干扰MEG3表达。采用蛋白质免疫印迹法检测转染细胞中DNMT1蛋白表达变化,采用细胞计数试剂盒-8(CCK-8)法和5-乙炔基-2'-脱氧尿苷(EdU)检测法检测细胞增殖变化。采用实时定量聚合酶链反应(qRT-PCR)检测转染后SO-RB50和HXO-RB44细胞中MEG3表达,采用甲基化特异性PCR检测干扰DNMT1表达后MEG3基因启动子的甲基化水平。
与正常RPE细胞相比,SO-RB50和HXO-RB44细胞中DNMT1蛋白表达显著增加(P<0.05)。在HXO-RB44细胞中,转染pcDNA-DNMT1后,DNMT1蛋白表达显著增加,细胞增殖能力增强,MEG3表达显著降低(P<0.05)。在SO-RB50细胞中,转染si-DNMT1后,DNMT1蛋白表达显著降低,细胞增殖受到抑制,MEG3表达增加(P<0.05)。干扰DNMT1可显著降低MEG3基因启动子的甲基化水平。在逆转DNMT1对MEG3基因的调控作用后,DNMT1蛋白对视网膜母细胞瘤细胞增殖的调控能力显著减弱(P<0.05)。
在视网膜母细胞瘤细胞中,DNMT1蛋白表达上调可诱导MEG3基因启动子甲基化及失活,最终导致细胞异常增殖。